Pharma major GlaxoSmithKline Pharmaceuticals (GSK) has launched ‘Trust in Science’ initiative in partnership with the Regional Centre for Biotechnology (RCB), to develop PhD courses in biostatistics and bioinformatics. A Vaidheesh, Vice President, South Asia and Managing Director, GSK tells more to Akanki Sharma
Kindly share a brief about the ‘Trust in Science’ programme. What does it offer and who are its beneficiaries?
Globally, GSK Pharmaceutical’s ‘Trust in Science’ initiative is a novel public-private partnership model to build R&D capacity for development and discovery in science. The pillars of this initiative are scientific excellence, trust and talent development in line with GSK’s science, technology and cultural values.
In India, we have launched the ‘Trust in Science’ initiative in partnership with the Regional Centre for Biotechnology (RCB), one of India’s academic research institutions to develop PhD courses in biostatistics and bioinformatics. The initiative covers scholarship costs and provides expert guidance to 12 students, so that they can complete their doctoral degrees. Any student with a master’s degree in biostatistics and bioinformatics is eligible to apply for this programme.
What prompted you to initiate a doctoral programme for bioinformatics and biostatistics only? How do you think it is going to benefit the pharma sector in India?
Our industry is generating huge amounts of biological and genomic data. This means we are dealing with massive data sets which were unimaginable some 20 years ago. Now comes the challenge of mining this data for insights and trends which can be extrapolated in a way that leads us to think and plan our future more strategically. Both bioinformatics and biostatistics offer immense promise here. Both the fields can drive the investigation and processing of large sets of biological information in a short period of time. This is of great value to a country like ours, with large sample sizes and varying factors that influence disease and healthcare delivery.
Bu hikaye Express Pharma dergisinin August 01-15, 2019 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin August 01-15, 2019 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
MAKING SUSTAINABILITY SUSTAINABLE
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability
New energy recovery system for tablet coaters
Upto 50 per cent less steam energy consumption
The future of pharma logistics: Trends, challenges, and opportunities
Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.